Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalaycio

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|August 30, 2011
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDSR M Sobecks, L Rybicki, M Yurch, et al.
Bone Marrow Transplantation|September 17, 2008
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphomaE Copelan, B Pohlman, L Rybicki, et al.
Bone Marrow Transplantation|August 19, 2007
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemiaM Kalaycio, L Rybicki, B Pohlman, et al.
Bone Marrow Transplantation|October 31, 2002
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantationB J Bolwell, M Kalaycio, R Sobecks, et al.
Bone Marrow Transplantation|July 20, 2004
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?W H W Tang, S Thomas, M Kalaycio, et al.
Bone Marrow Transplantation|March 24, 2015
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whitesB K Hamilton, L Rybicki, M Sekeres, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
Bone Marrow Transplantation|February 10, 2015
Outcomes after autologous SCT in lymphoma patients grouped by weightJ E Lau, C Weber, M Earl, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|July 10, 2007
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignanciesB J Bolwell, B Pohlman, L Rybicki, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|August 30, 2011
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDSR M Sobecks, L Rybicki, M Yurch, et al.
Bone Marrow Transplantation|September 17, 2008
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphomaE Copelan, B Pohlman, L Rybicki, et al.
Bone Marrow Transplantation|August 19, 2007
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemiaM Kalaycio, L Rybicki, B Pohlman, et al.
Bone Marrow Transplantation|October 31, 2002
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantationB J Bolwell, M Kalaycio, R Sobecks, et al.
Bone Marrow Transplantation|July 20, 2004
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?W H W Tang, S Thomas, M Kalaycio, et al.
Bone Marrow Transplantation|March 24, 2015
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whitesB K Hamilton, L Rybicki, M Sekeres, et al.
Bone Marrow Transplantation|March 23, 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTD M Mickelson, L Sproat, R Dean, et al.
Bone Marrow Transplantation|February 10, 2015
Outcomes after autologous SCT in lymphoma patients grouped by weightJ E Lau, C Weber, M Earl, et al.
Bone Marrow Transplantation|February 2, 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipientsR Avery, B Pohlman, K Adal, et al.
Bone Marrow Transplantation|July 10, 2007
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignanciesB J Bolwell, B Pohlman, L Rybicki, et al.
Pageof 7